309 related articles for article (PubMed ID: 20467190)
1. Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by MDCT in patients with suspected coronary artery disease.
Shiga Y; Miura S; Mitsutake R; Kawamura A; Uehara Y; Saku K
J Atheroscler Thromb; 2010 Aug; 17(8):870-8. PubMed ID: 20467190
[TBL] [Abstract][Full Text] [Related]
2. Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population.
Huang YC; Ho CC; Lin PT; Lee BJ; Lai CH; Liaw YP
Nutr Res; 2010 Jan; 30(1):21-6. PubMed ID: 20116656
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
4. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
[TBL] [Abstract][Full Text] [Related]
5. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
7. HDL
Chaudhary R; Kinderytė M; Chaudhary R; Sukhi A; Bliden K; Tantry U; Gurbel P
Cardiovasc Revasc Med; 2019 Nov; 20(11):1001-1006. PubMed ID: 30626544
[TBL] [Abstract][Full Text] [Related]
8. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol Control for Subclinical Coronary Atherosclerosis in Subjects Without Indication for Statin Therapy.
Park HW; Kim YG; Park GM; Park S; Cho YR; Suh J; Lee Y; Yang DH; Kang JW; Kim HK; Choe J; Kim YH; Lee SW
Am J Cardiol; 2021 Aug; 153():51-57. PubMed ID: 34176598
[TBL] [Abstract][Full Text] [Related]
11. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness.
Orem C; Durmuş I; Kilinç K; Baykan M; Gökçe M; Orem A; Topbaş M
Coron Artery Dis; 2003 May; 14(3):219-24. PubMed ID: 12702925
[TBL] [Abstract][Full Text] [Related]
12. HDL-associated factors provide additional prognostic information for coronary artery disease as determined by multi-detector row computed tomography.
Mitsutake R; Miura S; Zhang B; Saku K
Int J Cardiol; 2010 Aug; 143(1):72-8. PubMed ID: 19237208
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
14. Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis.
Kou T; Luo H; Yin L
BMC Cardiovasc Disord; 2021 Mar; 21(1):127. PubMed ID: 33676400
[TBL] [Abstract][Full Text] [Related]
15. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.
Alber HF; Wanitschek MM; de Waha S; Ladurner A; Suessenbacher A; Dörler J; Dichtl W; Frick M; Ulmer H; Pachinger O; Weidinger F
Eur J Clin Invest; 2008 Jun; 38(6):372-80. PubMed ID: 18489399
[TBL] [Abstract][Full Text] [Related]
17. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
18. The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
Brener SJ; Ivanc TB; Hu T
J Invasive Cardiol; 2008 Jun; 20(6):261-5. PubMed ID: 18523316
[TBL] [Abstract][Full Text] [Related]
19. High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.
Omote K; Yokota I; Nagai T; Sakuma I; Nakagawa Y; Kamiya K; Iwata H; Miyauchi K; Ozaki Y; Hibi K; Hiro T; Fukumoto Y; Mori H; Hokimoto S; Ohashi Y; Ohtsu H; Ogawa H; Daida H; Iimuro S; Shimokawa H; Saito Y; Kimura T; Matsuzaki M; Nagai R; Anzai T
J Atheroscler Thromb; 2022 Jan; 29(1):50-68. PubMed ID: 33431716
[TBL] [Abstract][Full Text] [Related]
20. Statin prescription strategies and atherogenic cholesterol goals attainment in Lebanese coronary artery disease patients.
Lama S; Souraya D; Youssef F
Int J Clin Pharm; 2017 Aug; 39(4):919-926. PubMed ID: 28523462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
